• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Hookipa Biotech - Articles and news items

First-in-human study of CMV vaccine HB-101 starts

Industry news / 20 July 2016 / Victoria White, Digital Content Producer

Hookipa Biotech has announced the start of a first-in-human study to evaluate the safety and immunogenicity of HB-101 against human cytomegalovirus…


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +